Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2025-12-24 @ 2:35 PM
NCT ID:
NCT01990859
Brief Title:
Phase 2 Study of Ipilimumab in Japanese Advanced Melanoma Patients
Official Title:
Phase 2 Study of Ipilimumab in Japanese Subjects With Unresectable or Metastatic Melanoma
Study:
NCT01990859
Protocol Section:
NCT01990859